Victory Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Victory Capital Management's RCUS Position: Q3 2026 in Review
Victory Capital Management increased its Arcus Biosciences (RCUS) stake by 141% in Q3 2026, buying an estimated $552K and bringing the position to 33,487 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.
Victory Capital Management first reported a position in RCUS in Q3 2019 and has held it in 28 quarters since. The position peaked at $43M in Q1 2021. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Victory Capital Management held 33,487 shares of Arcus Biosciences worth $865K as of Q3 2026.
- Victory Capital Management bought 19,587 Arcus Biosciences shares in Q3 2026, an estimated $552K.
- Arcus Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1995 holding.
- Victory Capital Management first reported a position in Arcus Biosciences in Q3 2019 and has held it in 28 quarters since.
- Victory Capital Management's Arcus Biosciences position peaked at $43M in Q1 2021.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.